Branched Aortic Arch Study

Sponsor
Timothy Chuter, MD (Other)
Overall Status
Recruiting
CT.gov ID
NCT00488696
Collaborator
(none)
25
1
1
242
0.1

Study Details

Study Description

Brief Summary

This is a study to assess the safety and effectiveness of endovascular treatment of aortic aneurysms involving the proximal aortic arch. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Condition or Disease Intervention/Treatment Phase
  • Device: Endovascular Bifurcated Stent-Graft
N/A

Detailed Description

An aneurysm is a localized bulge in the wall of an artery. Aneurysms of the aorta are prone to progressive dilatation, which if left untreated ultimately results in rupture, internal bleeding and death. Traditional open surgery involves aortic exposure through a long incision, aortic clamping to interrupt blood flow, and replacement or repair of the dilated aortic segment using a fabric conduit (graft), which is sutured (anastomosis) to the nondilated arteries above and below the aneurysm. Some subjects are able to withstand such a large operation better than others, but many suffer complications, and all suffer pain, debility, and a lengthy stay in hospital.

Endovascular aneurysm repair is a less invasive alternative that substitutes a trans-arterial route to the aneurysm for direct exposure, and stent-mediated attachment for sutured anastomosis. Compared to open surgical repair, endovascular repair is associated with less physiological derangement, less pain, less blood loss, lower complication rates and shorter hospital stay. Consequently, endovascular repair has become standard therapy for aneurysms of the abdominal aorta and descending thoracic aorta, where there are no vital branches and endovascular exclusion rarely causes ischemic complications.

Open surgical repair of the proximal aortic arch requires hypothermic circulatory arrest, because it deprives the heart of its outflow and the brain of its inflow. Endovascular repair also obstructs outflow from the heart, but only for a few seconds, while the graft is released from its delivery sheath. The greater problem is inflow to the brain. In anticipation of aortic arch exclusion, the brachiocephalic circulation requires an alternative source of blood. One alternative is bypass from the ascending aorta. However, this requires median sternotomy and partial aortic clamping, both of with are potential sources of morbidity.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Branched Stent-Graft Repair for Endo Repair of Aneurysms Involving the Proximal Aortic Arch
Study Start Date :
Oct 1, 2006
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional

Endovascular Bifurcated Stent Graft: The investigational operation involves placing a stent-graft over the aortic aneurysm.

Device: Endovascular Bifurcated Stent-Graft
Treatment of Aneurysm involving the proximal aortic arch with endovascular bifurcated stent-graft.

Outcome Measures

Primary Outcome Measures

  1. Successful implantation of bifurcated stent-graft for repair of Aneurysm involving the proximal aortic arch [1 month]

Secondary Outcome Measures

  1. Stability of bifurcated stent-graft for repair of Aneurysm involving the proximal aortic arch [5 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aneurysm of the aortic arch larger than 6cm in diameter, or symptomatic aneurysm of the aortic arch, of any diameter, or any arch aneurysm with a 2-year rupture rate estimated to be more than 20%.

  • Anticipated mortality rate with open repair estimated to be more than 20%.

  • Suitable arterial anatomy for stent-graft

  • Life expectancy more than 2 years

  • Ability to give informed consent and willingness to comply with follow-up schedule

Exclusion Criteria:
  • Free rupture of the aneurysm

  • Pregnancy

  • Anaphylactic reaction to contrast material

  • Allergy to stainless steel or polyester

  • Unwillingness or inability to comply with the follow-up schedule

  • Serious systemic or groin infection

  • Uncorrectable coagulopathy

  • Significant presence of carotid artery atherosclerosis

  • Arrhythmia define as 2nd- and 3rd-degree atrioventricular block or sinus node disease, such as sick sinus syndrome and symptomatic bradycardia, unless the patient already has a pacemaker in place and cardiology consultation confirms that it is safe to proceed.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCSF Division of Vascular and Endovascular Surgery San Francisco California United States 94143

Sponsors and Collaborators

  • Timothy Chuter, MD

Investigators

  • Principal Investigator: Linda M Reilly, MD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Timothy Chuter, MD, Principal Investigator, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00488696
Other Study ID Numbers:
  • 10-03930
First Posted:
Jun 20, 2007
Last Update Posted:
Jul 22, 2021
Last Verified:
Jul 1, 2021
Keywords provided by Timothy Chuter, MD, Principal Investigator, University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2021